{
  "AKRO": "Positive MASH Study Results",
  "EXOD": "Positive MASH Study Results",
  "APP": "Highlighted as Zacks Bull and Bear of the Day",
  "PLTR": "Institutional Investors Control 49% and Were Rewarded",
  "IONQ": "Wall Street Analysts Look Optimistic",
  "DSP": "Price Target Raised Amid Optimistic Q4 Outlook",
  "CVNA": "Intrinsic Value Potentially 87% Above Share Price",
  "ELMD": "Theravance Bio Soars 8.3%",
  "ECOR": "Theravance Bio Soars 8.3%"
}